New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 30, 2014
08:39 EDTSQNMSequenom should be bought following solid Q2, says Maxim
Maxim raised its price target for Sequenom shares to $7 from $6 and recommends buying the stock following the company's "solid" Q2 results. Maxim expects Sequenom to regain its leadership position after the firm's channel checks in Q2 indicated Ariosa's U.S. volume may have surpassed Sequenom for the first time in Q2. It keeps a Buy rating on the stock.
News For SQNM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for SQNM

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use